Aller au contenu principal
Profil bibliographique

Hannah Fox

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

42Publications signalées
344Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Head and Neck Cancer StudiesReconstructive Surgery and Microvascular TechniquesTracheal and airway disordersCOVID-19 Clinical Research StudiesPalliative Care and End-of-Life Issues

Les publications récentes

Accès ouvert 2025 article OpenAlex

Cambridge kidney One-Stop Mass Investigation Clinic (CkOSMIC): A Nonrandomised Feasibility Study

Chiara Re, James Peter Blackmur, Teele Kuusk, Thomas J. Mitchell et autres

BACKGROUND AND OBJECTIVE: Our aim was to evaluate the feasibility and outcomes of a one-stop renal mass biopsy (RMB) clinic at which same-day biopsy results were facilitated by the use of confocal microscopy. METHODS: The Cambridge kidney One-Stop Mass Investigation Clinic (CkOSMIC) …

gb (code pays fourni par la source)

2 citations European Urology Oncology
Accès ouvert 2025 article OpenAlex

Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Amr E. Abbas, Fatima H. Abbas, Kaja Abbas et autres

BACKGROUND: Sotrovimab is a neutralising monoclonal antibody targeting the SARS-CoV-2 spike protein. We aimed to evaluate the efficacy and safety of sotrovimab in the RECOVERY trial, an investigator-initiated, individually randomised, controlled, open-label, adaptive platform trial testing treatments for patients admitted to hospital …

0 citations The Lancet Infectious Diseases
Accès ouvert 2025 article OpenAlex

Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Amr E. Abbas, Fatima H. Abbas, Jonathan Raihan Abbas et autres

BACKGROUND: Molnupiravir and nirmatrelvir-ritonavir are oral antivirals that have shown efficacy in preventing disease progression in outpatients with COVID-19. We aimed to evaluate these treatments for patients hospitalised with COVID-19 pneumonia, for whom data on these antivirals are scarce. METHODS: The RECOVERY …

11 citations The Lancet Infectious Diseases
Accès ouvert 2025 article OpenAlex

Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Amr E. Abbas, Fatima H. Abbas, Jaffar Abbas et autres

Background: Low dose corticosteroids (e.g., 6 mg dexamethasone) have been shown to reduce mortality for hypoxic COVID-19 patients. We have previously reported that higher dose corticosteroids cause harm in patients with clinical hypoxia but not receiving ventilatory support (the combination of non-invasive …

3 citations EClinicalMedicine
Accès ouvert 2023 article OpenAlex

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Amr E. Abbas, Fatima H. Abbas, Jonathan Raihan Abbas et autres

BACKGROUND: Empagliflozin has been proposed as a treatment for COVID-19 on the basis of its anti-inflammatory, metabolic, and haemodynamic effects. The RECOVERY trial aimed to assess its safety and efficacy in patients admitted to hospital with COVID-19. METHODS: In the randomised, controlled, …

41 citations The Lancet Diabetes & Endocrinology
Accès ouvert 2023 conference-abstract OpenAlex

P43 Patient tolerability of adalimumab biosimilar therapy in dermatology and rheumatology: real-world experience from a large tertiary centre

Arlene McGuire, Sarah Guard, Karen Topping, Catherine Smith et autres

Abstract Adalimumab is widely used in the treatment of immune-mediated inflammatory diseases. It is the highest-spend drug in the National Health Service, costing more than £400 million annually. In 2018, adalimumab biosimilars became available, leading to substantial cost savings. However, patient tolerability …

gb (code pays fourni par la source)

1 citation British Journal of Dermatology
Accès ouvert 2023 conference-paper OpenAlex

112 What does an out of hours consultant led palliative care advisory service look like?

Hannah Fox, Paula Hall, Charlotte Healey, Barry J. A. Laird et autres

Background Supportive Care UK provides a nationwide remote palliative consultant led service to support medical professionals. This study aimed to characterise the nature of calls made to their out of hours (OOH) helpline. Methods Retrospective review of 126 anonymised call logs, documenting …

3 citations Poster presentations
2022 article OpenAlex

Robotic lateral oropharyngectomy following diagnostic tonsillectomy is oncologically safe in patients with human papillomavirus‐related squamous cell cancer: Long‐term results

Somiah Siddiq, S. Stephen, Daniel J. Lin, Hannah Fox et autres

INTRODUCTION: To report the long-term oncological and functional outcomes of en bloc TORS lateral oropharyngectomy to address the close/involved margin following diagnostic tonsillectomy in HPV-related SCC of unknown primary. MATERIAL AND METHODS: A single tertiary center observational cohort over a 4-year period. …

gb (code pays fourni par la source)

2 citations Head & Neck
Accès ouvert 2022 article OpenAlex

Quantifying the health needs of migrants in vulnerable circumstances registered with a nurse-led primary care service

Emily Clark, Hannah Fox, T Berger Gillam, Clodagh Clarry

Background: As of the end of 2019, at least 79.5 million people worldwide have been forced to flee their homes. Those seeking asylum face adversity before, during and after arrival in the UK, resulting in complex health and social needs. The study …

gb (code pays fourni par la source)

3 citations Journal of research in nursing
Accès ouvert 2022 conference-abstract OpenAlex

P-99 Completion of an advance care plan (ACP) with patients with advanced neurological conditions, the evidence

Hannah Fox, Julia Head, Eleanor Hendicott, Derek Willis

Background As a result of service development through COVID-19, a community based Speciality Doctor was recruited to write ACPs for patients with progressive advanced neurological conditions through domiciliary visits. This study seeks to understand how their ACP may benefit patients and their …

gb (code pays fourni par la source)

0 citations Poster presentations

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.